FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology and can be used for therapy of patients suffering from hepatic metastases of gastric carcinoma. The mode is implemented as follows. Celiac trunk is catheterised through femoral artery by Seldinger approach. That is followed with selective catheterisation of common hepatic artery wherein Cisplatin is injected within 24 hours, and Fluorouracil - within the next 72 hours. Therapeutic course includes 4-6 procedures every 4 weeks.
EFFECT: invention use allows downsizing the metastatic foci, extending life span and improving life quality of said patients.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF NEOADJUVANT CHEMOTHERAPY OF TNM STAGE STOMACH CANCER | 2008 |
|
RU2372902C1 |
METHOD OF PERSONALIZED NEOADJUVANT INTRA-ARTERIAL CHEMOTHERAPY OF GASTRIC CANCER | 2021 |
|
RU2797397C2 |
METHOD FOR TREATING PATIENTS WITH COLORECTAL CANCER AND WITH RENAL METASTASES | 2005 |
|
RU2297219C2 |
METHOD OF STOMACH CARCINOMA TREATMENT | 1996 |
|
RU2134549C1 |
METHOD OF TREATING PATIENTS SUFFERING FROM COLORECTAL CANCER WITH LIVER METASTASES | 2007 |
|
RU2372089C2 |
CERVICAL CANCER NEOADJUVANT CHEMOTHERAPY METHOD | 2009 |
|
RU2405544C1 |
METHOD OF TREATING OPERABLE GASTRIC ADENOCARCINOMA | 2019 |
|
RU2706346C1 |
METHOD OF TREATING MALIGNANT GASTRIC AND DUODENAL TUMOURS | 2010 |
|
RU2436605C1 |
METHOD OF TREATING INOPERABLE PANCREATIC ADENOCARCINOMA WITH LIVER METASTASES | 2019 |
|
RU2706786C1 |
METHOD OF TREATING INOPERABLE PANCREATIC HEAD ADENOCARCINOMA | 2019 |
|
RU2706341C1 |
Authors
Dates
2009-08-20—Published
2008-06-16—Filed